<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT
TO SECTION 13 OR 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): September&nbsp;12, 2013 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g597375tx_pg001.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>GENTIVA HEALTH SERVICES, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>1-15669</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>36-4335801</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File No.)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>3350 Riverwood Parkway, Suite 1400, Atlanta, Georgia</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>30339-3314</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(770) 951-6450 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s telephone number, including area code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Not applicable </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former
name or former address, if changed since last report) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) In a letter to shareholders dated May&nbsp;2, 2013, the Lead Director and Chairman of the
Compensation Committee (&#147;Compensation Committee&#148;) of Gentiva Health Services, Inc. (the &#147;Company&#148;), together with the Company&#146;s Executive Chairman, advised that, among other matters, changes to the Company&#146;s
compensation program would be made to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) replace the &#147;single trigger&#148; acceleration of vesting of equity awards upon a change
in control with a &#147;double trigger&#148;; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) adopt a &#147;claw back&#148; policy; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) extend the performance measurement period for compensation paid under the long-term incentive performance award program beyond a
one-year measuring period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the letter stated that the Compensation Committee would consider the use of a total shareholder return adjustment
feature with respect to payments made under the long-term incentive performance award element of the compensation program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective
September&nbsp;12, 2013, the Compensation Committee and the Board of Directors of the Company (the &#147;Board&#148;) implemented all of these changes to the compensation program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The first two changes were accomplished by the approval and adoption, as applicable, of (i)&nbsp;the Gentiva Health Services, Inc. Executive
Incentive Compensation Recoupment Policy (the &#147;Recoupment Policy&#148;), (ii)&nbsp;Amendment No.&nbsp;2 to the Gentiva Health Services, Inc. 2004 Equity Incentive Plan (amended and restated as of March&nbsp;16, 2011), as amended by Amendment
No.&nbsp;1 thereto (the &#147;Equity Plan&#148;), and (iii)&nbsp;Amendment No.&nbsp;1 to the Gentiva Health Services, Inc. Executive Officers Bonus Plan (the &#147;Bonus Plan&#148;). The third change was accomplished by amendments to awards made in
2013. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Recoupment Policy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Recoupment Policy generally permits the Company to recover from a &#147;covered employee&#148; any incentive compensation (which includes
equity awards and cash bonuses) awarded or paid on or after September&nbsp;12, 2013 and within three years prior to: (i)&nbsp;any restatement of the Company&#146;s financial statements due to material noncompliance with any financial reporting
requirement under the securities laws that, had the Company&#146;s financial statements conformed to the restatement when originally presented, would have resulted in less incentive compensation awarded or paid to the covered employee or
(ii)&nbsp;the date the Compensation Committee determines incentive compensation was awarded or paid to the covered employee based on inaccurate financial statements or on performance measurements, calculations or other data that were inaccurately
determined. The Recoupment Policy also memorializes the Compensation Committee&#146;s adoption of a general Dodd-Frank &#147;claw back&#148; policy as already authorized by Section&nbsp;2(b) of the Equity Plan, which &#147;claw back&#148; policy
applies to all awards granted under the Equity Plan on or after March&nbsp;16, 2011. A &#147;covered employee&#148; is generally any current or former executive officer of the Company or any current or former employee the Compensation Committee
designates to be subject to the Recoupment Policy. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Equity Plan and Bonus Plan Amendments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Equity Plan and the Bonus Plan were amended to (i)&nbsp;provide that the lapse of certain restrictions on awards granted on or after
September&nbsp;12, 2013 under the Equity Plan for a change of control shall not apply unless the grantee&#146;s employment also is terminated (except in limited cases where a buyer chooses not to assume awards) following the change of control (i.e.,
a &#147;double trigger&#148;), and (ii)&nbsp;make awards granted on or after September&nbsp;12, 2013 under both plans subject to the Recoupment Policy if the grantee is a &#147;covered employee&#148; under the Recoupment Policy. The amendments were
effective upon approval by the Compensation Committee and Board, as applicable, and do not require shareholder approval. The description of the changes to the Equity Plan is qualified in its entirety by reference to Amendment No.&nbsp;2 to the
Equity Plan, filed as Exhibit 10.1 to this Current Report on Form 8-K, which is incorporated herein by reference. The description of the changes to the Bonus Plan is qualified in its entirety by reference to Amendment No.&nbsp;1 to the Bonus Plan,
filed as Exhibit 10.2 to this Current Report on Form 8-K, which is incorporated herein by reference. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Amendment&nbsp;&amp; Consent to
2013 Awards </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To ensure that the replacement of &#147;single trigger&#148; with &#147;double trigger&#148; vesting and the adoption of a
&#147;claw back&#148; policy apply to stock options, restricted stock awards and performance cash awards granted under the Equity Plan on February&nbsp;19, 2013 (the &#147;2013 Awards&#148;) to the Company&#146;s named executive officers
(&#147;NEOs&#148;), and to implement the extension of the performance measurement period for compensation paid under the long-term incentive performance award program beyond a one-year measuring period (including the use of a total shareholder
return adjustment), the Company and each of the NEOs entered into an Amendment&nbsp;&amp; Consent to 2013 Awards, providing that (i)&nbsp;the 2013 Awards will no longer be subject to &#147;single trigger&#148; vesting upon a change in control but
instead to &#147;double trigger&#148; vesting upon a termination of employment without &#147;cause&#148; or for &#147;good reason&#148; within two years following a change in control, (ii)&nbsp;the 2013 Awards will be subject to the Recoupment
Policy, (iii)&nbsp;the &#147;one-year&#148; performance cash awards will be subject to &#147;earnings per share&#148; performance targets measured over the 2015 fiscal year (instead of over the 2013 fiscal year as previously provided), and
(iv)&nbsp;all of the performance cash awards will be subject to a three-year performance period in which the Company&#146;s &#147;total shareholder return&#148; will be compared to its peer group&#146;s &#147;total shareholder return&#148; during
the three-year performance period covering fiscal years 2013, 2014 and 2015, and the total payout (if any) under the performance cash awards will be adjusted 20% higher if the Company achieves a positive total shareholder return and finishes first
(or tied for first) compared to its peer group or 20% lower if the Company finishes last (or tied for last) compared to its peer group. If the Company does not finish first (or tied for first) or last (or tied for last) compared to its peer group,
there will be no adjustment to any payout. The Company&#146;s peer group will normally consist of the publicly-traded companies listed under the heading &#147;Shareholder Return Performance Graph&#148; in Item&nbsp;5 of Part II of the Company&#146;s
Form 10-K for the fiscal year ending on December&nbsp;31, 2012. The description of the Amendment&nbsp;&amp; Consent to 2013 Awards is qualified in its entirety by reference to the Form of Amendment and Consent to 2013 Awards filed as Exhibit 10.3 to
this Current Report on Form 8-K, which is incorporated herein by reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, the Company&#146;s Executive Chairman, Rodney
Windley, entered into an Amendment&nbsp;&amp; Consent to 2013 Stock Options to amend his stock options granted under the Equity Plan on April&nbsp;4, 2013 (the &#147;2013 Stock Options&#148;) to provide that (i)&nbsp;the time service conditions for
the 2013 Stock Options will no longer be subject to &#147;single trigger&#148; vesting upon a change in control but instead to &#147;double trigger&#148; vesting upon a termination of employment without &#147;cause&#148; or for &#147;good
reason&#148; within two years following a change in control, or upon a change in control if the Compensation Committee determines that such termination of employment within one year before any change in control was in connection with, or in
anticipation of, the change in control, and (ii)&nbsp;the 2013 Stock Options will be subject to the </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Recoupment Policy. The description of the Amendment&nbsp;&amp; Consent to 2013 Stock Options is qualified in its
entirety by reference to the Amendment&nbsp;&amp; Consent to 2013 Stock Options filed as Exhibit 10.4 to this Current Report on Form 8-K, which is incorporated herein by reference. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top">The following exhibits are filed with this Current Report on Form 8-K: </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:23.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit<BR>No.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Description</P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Amendment No. 2 to the Gentiva Health Services, Inc. 2004 Equity Incentive Plan (amended and restated as of March&nbsp;16, 2011), as amended by Amendment No. 1.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Amendment No. 1 to the Gentiva Health Services, Inc. Executive Officers Bonus Plan.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Amendment &amp; Consent to 2013 Awards.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Amendment &amp; Consent to 2013 Stock Options.</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>GENTIVA HEALTH SERVICES, INC.</B></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John N. Camperlengo</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">John N. Camperlengo</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Senior Vice President, General Counsel and Secretary</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date:&nbsp;September 16, 2013 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:23.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit<BR>No.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Description</P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Amendment No. 2 to the Gentiva Health Services, Inc. 2004 Equity Incentive Plan (amended and restated as of March&nbsp;16, 2011), as amended by Amendment No. 1.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Amendment No. 1 to the Gentiva Health Services, Inc. Executive Officers Bonus Plan.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Amendment &amp; Consent to 2013 Awards.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Amendment &amp; Consent to 2013 Stock Options.</TD></TR>
</TABLE>
</BODY></HTML>
[{"type": "8-K", "sequence": "1", "filename": "d597375d8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 25714}]
{"company-data": {"conformed-name": "GENTIVA HEALTH SERVICES INC", "cik": "0001096142", "assigned-sic": "8082", "irs-number": "364335801", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-15669", "film-number": "131097942"}, "business-address": {"street1": "3350 RIVERWOOD PARKWAY", "street2": "SUITE 1400", "city": "ATLANTA", "state": "GA", "zip": "30339", "phone": "7709516450"}, "mail-address": {"street1": "3350 RIVERWOOD PARKWAY", "street2": "SUITE 1400", "city": "ATLANTA", "state": "GA", "zip": "30339"}, "former-company": {"former-conformed-name": "OLSTEN HEALTH SERVICES HOLDING CORP", "date-changed": "19991001"}}
Form 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT
TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 12, 2013
GENTIVA HEALTH SERVICES, INC.
(Exact name of registrant as specified in its charter)
Delaware
1-15669
36-4335801
(State or other jurisdiction
of incorporation)
(Commission
File No.)
(IRS Employer
Identification No.)
3350 Riverwood Parkway, Suite 1400, Atlanta, Georgia
30339-3314
(Address of principal executive offices)
(Zip Code)
(770) 951-6450
(Registrant's telephone number, including area code)
Not applicable
(Former
name or former address, if changed since last report)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers.
(e) In a letter to shareholders dated May 2, 2013, the Lead Director and Chairman of the
Compensation Committee ("Compensation Committee") of Gentiva Health Services, Inc. (the "Company"), together with the Company's Executive Chairman, advised that, among other matters, changes to the Company's
compensation program would be made to:
(i) replace the "single trigger" acceleration of vesting of equity awards upon a change
in control with a "double trigger";
(ii) adopt a "claw back" policy; and
(iii) extend the performance measurement period for compensation paid under the long-term incentive performance award program beyond a
one-year measuring period.
In addition, the letter stated that the Compensation Committee would consider the use of a total shareholder return adjustment
feature with respect to payments made under the long-term incentive performance award element of the compensation program.
Effective
September 12, 2013, the Compensation Committee and the Board of Directors of the Company (the "Board") implemented all of these changes to the compensation program.
The first two changes were accomplished by the approval and adoption, as applicable, of (i) the Gentiva Health Services, Inc. Executive
Incentive Compensation Recoupment Policy (the "Recoupment Policy"), (ii) Amendment No. 2 to the Gentiva Health Services, Inc. 2004 Equity Incentive Plan (amended and restated as of March 16, 2011), as amended by Amendment
No. 1 thereto (the "Equity Plan"), and (iii) Amendment No. 1 to the Gentiva Health Services, Inc. Executive Officers Bonus Plan (the "Bonus Plan"). The third change was accomplished by amendments to awards made in
2013.
Recoupment Policy
The Recoupment Policy generally permits the Company to recover from a "covered employee" any incentive compensation (which includes
equity awards and cash bonuses) awarded or paid on or after September 12, 2013 and within three years prior to: (i) any restatement of the Company's financial statements due to material noncompliance with any financial reporting
requirement under the securities laws that, had the Company's financial statements conformed to the restatement when originally presented, would have resulted in less incentive compensation awarded or paid to the covered employee or
(ii) the date the Compensation Committee determines incentive compensation was awarded or paid to the covered employee based on inaccurate financial statements or on performance measurements, calculations or other data that were inaccurately
determined. The Recoupment Policy also memorializes the Compensation Committee's adoption of a general Dodd-Frank "claw back" policy as already authorized by Section 2(b) of the Equity Plan, which "claw back" policy
applies to all awards granted under the Equity Plan on or after March 16, 2011. A "covered employee" is generally any current or former executive officer of the Company or any current or former employee the Compensation Committee
designates to be subject to the Recoupment Policy.
Equity Plan and Bonus Plan Amendments
The Equity Plan and the Bonus Plan were amended to (i) provide that the lapse of certain restrictions on awards granted on or after
September 12, 2013 under the Equity Plan for a change of control shall not apply unless the grantee's employment also is terminated (except in limited cases where a buyer chooses not to assume awards) following the change of control (i.e.,
a "double trigger"), and (ii) make awards granted on or after September 12, 2013 under both plans subject to the Recoupment Policy if the grantee is a "covered employee" under the Recoupment Policy. The amendments were
effective upon approval by the Compensation Committee and Board, as applicable, and do not require shareholder approval. The description of the changes to the Equity Plan is qualified in its entirety by reference to Amendment No. 2 to the
Equity Plan, filed as Exhibit 10.1 to this Current Report on Form 8-K, which is incorporated herein by reference. The description of the changes to the Bonus Plan is qualified in its entirety by reference to Amendment No. 1 to the Bonus Plan,
filed as Exhibit 10.2 to this Current Report on Form 8-K, which is incorporated herein by reference.
Amendment & Consent to
2013 Awards
To ensure that the replacement of "single trigger" with "double trigger" vesting and the adoption of a
"claw back" policy apply to stock options, restricted stock awards and performance cash awards granted under the Equity Plan on February 19, 2013 (the "2013 Awards") to the Company's named executive officers
("NEOs"), and to implement the extension of the performance measurement period for compensation paid under the long-term incentive performance award program beyond a one-year measuring period (including the use of a total shareholder
return adjustment), the Company and each of the NEOs entered into an Amendment & Consent to 2013 Awards, providing that (i) the 2013 Awards will no longer be subject to "single trigger" vesting upon a change in control but
instead to "double trigger" vesting upon a termination of employment without "cause" or for "good reason" within two years following a change in control, (ii) the 2013 Awards will be subject to the Recoupment
Policy, (iii) the "one-year" performance cash awards will be subject to "earnings per share" performance targets measured over the 2015 fiscal year (instead of over the 2013 fiscal year as previously provided), and
(iv) all of the performance cash awards will be subject to a three-year performance period in which the Company's "total shareholder return" will be compared to its peer group's "total shareholder return" during
the three-year performance period covering fiscal years 2013, 2014 and 2015, and the total payout (if any) under the performance cash awards will be adjusted 20% higher if the Company achieves a positive total shareholder return and finishes first
(or tied for first) compared to its peer group or 20% lower if the Company finishes last (or tied for last) compared to its peer group. If the Company does not finish first (or tied for first) or last (or tied for last) compared to its peer group,
there will be no adjustment to any payout. The Company's peer group will normally consist of the publicly-traded companies listed under the heading "Shareholder Return Performance Graph" in Item 5 of Part II of the Company's
Form 10-K for the fiscal year ending on December 31, 2012. The description of the Amendment & Consent to 2013 Awards is qualified in its entirety by reference to the Form of Amendment and Consent to 2013 Awards filed as Exhibit 10.3 to
this Current Report on Form 8-K, which is incorporated herein by reference.
Further, the Company's Executive Chairman, Rodney
Windley, entered into an Amendment & Consent to 2013 Stock Options to amend his stock options granted under the Equity Plan on April 4, 2013 (the "2013 Stock Options") to provide that (i) the time service conditions for
the 2013 Stock Options will no longer be subject to "single trigger" vesting upon a change in control but instead to "double trigger" vesting upon a termination of employment without "cause" or for "good
reason" within two years following a change in control, or upon a change in control if the Compensation Committee determines that such termination of employment within one year before any change in control was in connection with, or in
anticipation of, the change in control, and (ii) the 2013 Stock Options will be subject to the
Recoupment Policy. The description of the Amendment & Consent to 2013 Stock Options is qualified in its
entirety by reference to the Amendment & Consent to 2013 Stock Options filed as Exhibit 10.4 to this Current Report on Form 8-K, which is incorporated herein by reference.
Item 9.01
Financial Statements and Exhibits.
(d)
The following exhibits are filed with this Current Report on Form 8-K:
Exhibit
No.
Description
10.1
Amendment No. 2 to the Gentiva Health Services, Inc. 2004 Equity Incentive Plan (amended and restated as of March 16, 2011), as amended by Amendment No. 1.
10.2
Amendment No. 1 to the Gentiva Health Services, Inc. Executive Officers Bonus Plan.
10.3
Form of Amendment & Consent to 2013 Awards.
10.4
Amendment & Consent to 2013 Stock Options.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
GENTIVA HEALTH SERVICES, INC.
/s/ John N. Camperlengo
John N. Camperlengo
Senior Vice President, General Counsel and Secretary
Date: September 16, 2013
EXHIBIT INDEX
Exhibit
No.
Description
10.1
Amendment No. 2 to the Gentiva Health Services, Inc. 2004 Equity Incentive Plan (amended and restated as of March 16, 2011), as amended by Amendment No. 1.
10.2
Amendment No. 1 to the Gentiva Health Services, Inc. Executive Officers Bonus Plan.
10.3
Form of Amendment & Consent to 2013 Awards.
10.4
Amendment & Consent to 2013 Stock Options.